Course Description

This training program provides a thorough understanding of the principles, processes, and good practices for effective technology transfer in the pharmaceutical industry. The course covers the complete technology transfer lifecycle from initial planning through project close-out.

Technology transfer is defined as activities that transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realisation. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement. Successful transfers depend on robust project management processes combined with appropriate product and process understanding.

Participants will learn how to transfer analytical methods, drug-substance processes for both large molecules and small synthetic molecules, and drug-product manufacturing processes. The course addresses transfers between any two parties, whether internal to the same company or external to a contract manufacturing organization.

The program emphasizes science- and risk-based approaches derived from Quality by Design principles, including Quality Target Product Profile, Critical Quality Attributes, Critical Process Parameters, material attributes, design space, and control strategy. Knowledge management is a critical component that encompasses both explicit and tacit knowledge derived from experience.

Quality risk management principles are covered, including risk identification, risk analysis, risk evaluation, risk control, and risk review. Participants will learn to use tools such as Failure Mode and Effect Analysis and Ishikawa diagrams.

The course also addresses communication, partnership, cooperation, and coordination between sending and receiving units. Cultural differences between units must be recognized early with steps taken to ensure appropriate understanding and alignment.

A comparison of key regulatory guidance documents is provided to help participants understand the similarities and differences in global expectations for technology transfer and process validation.

Learning Objectives

Upon completion of this course, participants will be able to:

• Define technology transfer and explain its role within the pharmaceutical product lifecycle, including pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation.
• Identify and describe the key components of a control strategy, including parameters and attributes related to drug substance and drug product materials and components, facility and equipment operating conditions, in-process controls, finished product specifications, and associated methods and frequency of monitoring and control.
• Distinguish between sending unit and receiving unit roles and responsibilities including core functions such as quality, manufacturing, and process engineering, and auxiliary functions such as regulatory, supply chain, warehousing, and health safety and environment.
• Differentiate between explicit knowledge and tacit knowledge, and explain methods for capturing and transferring tacit knowledge.
• List and describe the six phases of technology transfer: Form Transfer Team and Develop Charter, Consolidate Knowledge and Develop Proposal, Identify Risks and Develop Plan, Operational Readiness, Process Qualification, and Finalize Transfer and Perform Review.
• Apply the stage-gate approach to technology transfer project management, including defining decision points and approval requirements before moving between phases.
• Develop a technology transfer charter that captures strategic intent, goals, milestones, roles and responsibilities, assumptions, constraints, and governance structure.
• Conduct a gap analysis between sending unit process requirements and receiving unit capabilities, identifying differences in equipment, facilities, procedures, and expertise.
• Perform quality risk assessments using Failure Mode and Effect Analysis methodology, including assigning scores for severity, occurrence, and detection, calculating risk priority numbers, and determining mitigation requirements.
• Execute analytical method transfers using the appropriate approach based on risk assessment and method criticality.
• Develop comparability protocols for demonstrating that product quality attributes have been maintained following technology transfer.
• Define success criteria for technology transfer projects including process performance metrics, product quality requirements, business parameters, and regulatory milestones.
• Analyze historical process data from the sending unit to establish baseline performance metrics and acceptance criteria for the receiving unit.
• Assess the impact of differences in equipment principles between sending and receiving units on process performance and product quality.
• Compare and contrast regulatory expectations from various global guidance documents regarding technology transfer and process validation.
• Design a technology transfer plan that integrates all six phases, including detailed timelines, resource requirements, risk mitigation actions, and success criteria.
• Create a RACI matrix for a technology transfer project, assigning clear roles and decision rights for each major activity.
• Develop a sampling plan for process qualification runs that includes appropriate sample points, sample sizes, testing requirements, and statistical analysis methods.
• Formulate a lessons learned documentation process that captures best practices and improvement opportunities for future technology transfers.

Course Scope

The scope of this training program includes technology transfers for analytical methods, drug substance for both large and small molecules, and drug product for various dosage forms. It addresses transfers that may take place at any point during the product lifecycle, including:

• Laboratory to laboratory scale transfers where methods or small-scale processes are moved between research or development laboratories.
• Laboratory to development or pilot scale transfers where processes are scaled up from bench-scale to pilot plant equipment.
• Development to clinical manufacturing transfers where processes are moved from development laboratories to facilities that produce clinical trial supplies.
• Development to launch or commercial manufacturing transfers where processes are scaled up and validated for commercial production.
• Commercial to commercial manufacturing transfers where processes are moved between existing commercial manufacturing sites.
• Drug substance to drug product manufacture transfers where drug substance is supplied to a drug product manufacturing site.
• Lead manufacturer to third party manufacturer transfers where production is outsourced to a contract manufacturing organization.

The sending and receiving units may be internal to the same company, external between companies, or external to a third party. The transfer is normally from a sending unit that possesses the process knowledge, history, and operational experience to a receiving unit that needs to acquire it.

Not all activities described in the course will apply to every transfer. Companies may select activities appropriate to the type and scale of technology transfer being performed. Early stage transfers may not require all the formal documentation and validation activities required for a commercial transfer.

Target Audience

This training program is intended for professionals involved in pharmaceutical development, manufacturing, quality, engineering, and project management. Specific roles include:

• Technology Transfer Project Managers and Team Leads responsible for overall project coordination, timeline management, resource allocation, and communication between units.
• Process Development Scientists for drug substance and drug product who develop the processes that will be transferred.
• Analytical Method Development and Quality Control Chemists responsible for transferring analytical methods.
• Manufacturing Operations and Technical Support Personnel who will operate the equipment and execute the manufacturing process.
• Quality Assurance and Quality Control Professionals responsible for approving protocols, reports, deviations, and change controls.
• Regulatory Affairs Specialists responsible for filing regulatory submissions and managing interactions with regulatory agencies.
• Engineering and Facilities Managers responsible for facility fit assessment, equipment selection, and qualification.
• Supply Chain and Material Management Planners responsible for sourcing raw materials and managing lead times.
• Contract Manufacturing Organization and Contract Development and Manufacturing Organization Personnel who receive technology from client companies.
• Health, Safety, and Environment Professionals responsible for assessing safety hazards and determining containment requirements.
• Statisticians responsible for designing sampling plans and analyzing comparability data.
• Senior Management and Governance Stakeholders responsible for approving budgets and resolving escalated issues.

Regulatory References Used to Design the Course

The course is designed using principles from key regulatory and industry guidance documents. These documents provide the framework for quality systems, pharmaceutical development, risk management, process validation, and technology transfer expectations.

Quality system guidance describes a model for an effective pharmaceutical quality system that covers the entire product lifecycle including pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation. It emphasizes knowledge management as a systematic approach to acquiring, analyzing, storing, and disseminating information. It establishes four elements of the quality system: process performance and product quality monitoring system, corrective action and preventive action system, change management system, and management review.

Pharmaceutical development guidance introduces Quality by Design principles and defines Quality Target Product Profile, Critical Quality Attributes, Critical Process Parameters, material attributes, design space, and control strategy. It states that demonstrating a greater understanding of pharmaceutical and manufacturing sciences can provide a basis for flexible regulatory approaches.

Quality risk management guidance provides principles and tools for managing risk throughout the product lifecycle. It defines the risk management process, including risk identification, risk analysis, risk evaluation, risk control, risk communication, and risk review. It introduces risk management tools including Failure Mode and Effect Analysis, Hazard and Operability Analysis, Fault Tree Analysis, and Ishikawa diagrams.

Drug substance development guidance provides approaches to developing and manufacturing drug substances for both chemical entities and biotechnological and biological entities. It introduces the concept of starting materials, their justification, and the control strategy for drug substance manufacturing.

Process validation guidance outlines three stages: Process Design, Process Qualification, and Continued Process Verification. It links Process Design to technology transfer requirements to understand what must be transferred, including Critical Quality Attributes, Critical Process Parameters, material attributes, and control strategy. It links Process Qualification to confirmation that the receiving unit can deliver the Critical Quality Attributes. It links Continued Process Verification to ensuring that the receiving unit implements monitoring to confirm successful technology transfer.

European guidance on process validation distinguishes between traditional process validation, continuous process verification, and hybrid approaches. It requires justification for the number of validation batches. Specific guidance for biotechnology-derived products addresses virus clearance validation, cell culture consistency, and other biologics-specific considerations.

Qualification and validation requirements provide binding requirements for design qualification, installation qualification, operational qualification, and performance qualification. They require a validation master plan and address cleaning validation and process validation.

Technology transfer guidelines provide organizational and management aspects including model technology transfer agreements and quality agreements. They address transfers to developing countries and specific challenges associated with such transfers, as well as transfer from research and development to manufacturing and between manufacturing sites.

Certification

Learners who successfully complete the program will receive a dated, traceable certificate that provides verifiable proof of their achievement for professional records.